Relation of antimullerian hormone with the clinical signs of hyperandrogenism and polycystic ovary morphology

References

• March WA, Moore VM, Willson KJ, et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010;25:544–51
   PubMed Web of Science ®Google Scholar
• Lee MM, Donahoe PK, Hasegawa T, et al. Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab 1996;81:571–6
   PubMed Web of Science ®Google Scholar
• Weenen C, Laven JS, Von Bergh AR, et al. Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 2004;10:77–83
   PubMed Web of Science ®Google Scholar
• Durlinger AL, Gruijters MJ, Kramer P, et al. Anti-Mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology 2002;143:1076–84
   PubMed Web of Science ®Google Scholar
• Durlinger AL, Visser JA, Themmen AP. Regulation of ovarian function: the role of anti-Mullerian hormone. Reproduction 2002;124:601–9
   PubMed Web of Science ®Google Scholar
• Sahmay S, Cetin M, Ocal P, et al. Serum anti-Müllerian hormone level as a predictor of poor ovarian response in in vitro fertilization patients. Reprod Med Biol 2011;10:9–14
   PubMedGoogle Scholar
• Ocal P, Sahmay S, Cetin M, et al. Serum anti-Müllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles. J Assist Reprod Genet 2011;28:1197–203
   PubMed Web of Science ®Google Scholar
• Pigny P, Jonard S, Robert Y, et al. Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J Clin Endocrinol Metab 2006;91:941–5
   PubMed Web of Science ®Google Scholar
• Cook CL, Siow Y, Brenner AG, et al. Relationship between serum Mullerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women. Fertil Steril 2002;77:141–6
   PubMed Web of Science ®Google Scholar
• Sahmay S, Atakul N, Oncul M, et al. Serum anti-Mullerian hormone levels in the main phenotypes of polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2013;170:157--61
   Google Scholar
• Das M, Gillott DJ, Saridogan E, et al. Anti-Mullerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary syndrome. Hum Reprod 2008;23:2122–6
   PubMed Web of Science ®Google Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group.Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41–7
   Google Scholar
• Sahmay S, Guralp O, Senturk LM, et al. Serum anti-mullerian hormone concentrations in reproductive age women with and without polycystic ovary syndrome: the influence of body mass index. Reprod Med Biol 2011;10:113–20
   PubMedGoogle Scholar
• Pellatt L, Rice S, Mason HD. Anti-Müllerian hormone and polycystic ovary syndrome: a mountain too high? Reproduction 2010;139:825–33
   PubMed Web of Science ®Google Scholar
• Xi W, Gong F, Lu G. Correlation of serum anti-Mullerian hormone concentrations on day 3 of the in vitro fertilization stimulation cycle with assisted reproduction outcome in polycystic ovary syndrome patients. J Assist Reprod Genet 2012;29:397–402
   PubMed Web of Science ®Google Scholar
• La Marca A, Broekmans FJ, Volpe A, et al. Anti-Mullerian hormone (AMH): what do we still need to know? Hum Reprod 2009;24:2264–75
   PubMed Web of Science ®Google Scholar
• Laven JS, Mulders AG, Visser JA, et al. Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab 2004;89:318–23
   PubMed Web of Science ®Google Scholar
• Piouka A, Farmakiotis D, Katsikis I, et al. Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels. Am J Physiol Endocrinol Metab 2009;296:E238–43
   PubMed Web of Science ®Google Scholar
• Sahmay S, Demirayak G, Guralp O, et al. Serum anti-müllerian hormone, follicle stimulating hormone and antral follicle count measurement cannot predict pregnancy rates in IVF/ICSI cycles. J Assist Reprod Genet 2012;29:589–95
   PubMed Web of Science ®Google Scholar
• Sahmay S, Guralp O, Aydogan B, et al. Anti-Mullerian hormone and polycystic ovary syndrome: assessment of the clinical pregnancy rates in in vitro fertilization patients. Gynecol Endocrinol 2013;29:440–3
   PubMed Web of Science ®Google Scholar
• La Marca A, Volpe A. Anti-Mullerian hormone (AMH) in female reproduction. is measurement of circulating AMH a useful tool? Clin Endocrinol 2006;64:603–10
   PubMed Web of Science ®Google Scholar
• Hickey TE, Marrocco DL, Amato F, et al. Androgens augment the mitogenic effects of oocyte-secreted factors and growth differentiation factor 9 on porcine granulosa cells. Biol Reprod 2005;73:825–32
   PubMed Web of Science ®Google Scholar
• Rosenfield RL, Wroblewski K, Padmanabhan V, et al. Antimuullerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries. Fertil Steril 2012;98:242–9
   PubMed Web of Science ®Google Scholar
• Eilertsen TB, Vanky E, Carlsen SM. Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced? Hum Reprod 2012;27:2494–502
   PubMed Web of Science ®Google Scholar
• Broer SL, Mol B, Dólleman M, et al. The role of anti-Müllerian hormone assessment in assisted reproductive technology outcome. Curr Opin Obstet Gynecol 2010;22:193–201
   PubMed Web of Science ®Google Scholar
• Fábregues F, Castelo-Branco C, Carmona F, et al. The effect of different hormone therapies on anti-Mullerian hormone serum levels in anovulatory women of reproductive age. Gynecol Endocrinol 2011;27:216–24
   PubMed Web of Science ®Google Scholar
• Carlsen SM, Vanky E, Fleming R. Anti-Müllerian hormone concentrations in androgen-suppressed women with polycystic ovary syndrome. Hum Reprod 2009;24:1732–8
   PubMed Web of Science ®Google Scholar
• Yildiz BO, Bolour S, Woods K, et al. Visually scoring hirsutism. Hum Reprod Update 2010;16:51–64
   PubMed Web of Science ®Google Scholar
• Dewailly D, Pigny P, Soudan B, et al. Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Müllerian hormone concentrations aggregate with the markers of hyperandrogenism. J Clin Endocrinol Metab 2010;95:4399–405
   PubMed Web of Science ®Google Scholar
• La Marca A, Sighinolfi D, Radi D, et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update 2010;16:113–30
   PubMed Web of Science ®Google Scholar